Without giving it any thought, the majority of people grab for their phones dozens of times per day. A fast scroll, a quick look at the time, a text message—all of these exchanges seem routine. However, experts looking at what those interactions tell about health are coming to a different conclusion: your phone knows a surprising amount about your body, and if the correct AI processes that data, it might ultimately know more than your yearly physical.
In recent years, the concept of utilizing smartphones to identify illness before symptoms appear has become much more feasible. A portion of this is powered by hardware that is already in people’s wrists and pockets. Accelerometers monitor both movement and the quality of sleep. Breathing noises and cough patterns can be captured using microphones. The technique known as photoplethysmography, which most people are more familiar with as the green light blinking on the back of their smartwatch, uses cameras to track changes in blood flow through minute variations in skin color that are visible to optical sensors. No new gadget is needed for any of this. To understand what has previously been measured, the appropriate software is needed.
Heart rhythm is the subject of the most convincing clinical data to date. A 2024 University of South Australia review of 28 studies revealed that wearable devices can detect atrial fibrillation with a sensitivity of 94.2 percent and specificity of 95.3 percent. These results are comparable to clinical-grade 12-lead ECGs. Apple Watch monitoring was found to be able to identify new-onset AF instances that standard care would have missed in a 2025 randomized controlled study conducted in the Netherlands on patients over 65 with elevated stroke risk.
Until it results in a stroke, atrial fibrillation frequently shows no symptoms. That is precisely the situation in which early detection is very important. According to the same analysis, wearables were able to identify COVID-19 with 87.5% accuracy prior to patients being tested. They were able to identify physiological changes, especially in heart rate and sleep disturbance, that came before the typical symptoms.
What behavioral data from phones may show is more intriguing, but it’s also more difficult to measure. Researchers have been investigating what they refer to as “digital behavioral phenotyping,” which is the theory that subtle variations in a person’s gadget usage can indicate changes in their physical or mental well-being. Typing becomes slower. Patterns of scrolling vary. Unusual hours lead to an increase in screen time. Sleep patterns fluctuate. When these signals are fed into machine learning models trained on data from individuals who subsequently acquired anxiety, depression, or early cognitive decline, they begin to generate patterns that physicians are starting to take seriously. However, none of these signals is diagnostic on its own.
The enthusiasm in this field has sometimes surpassed the evidence, so it’s important to be clear about the limitations. There are serious concerns regarding how well these systems function across various skin tones, age groups, and body types because accuracy varies greatly across different populations. The majority of research have included people who are primarily white and older. For example, due to variations in light absorption, consumer gadgets‘ photoplethysmography sensors are known to be less accurate on darker skin. In a system that hundreds of millions of people use, false positives would result in a significant clinical burden, including needless follow-up appointments, worry, and strained healthcare resources in already overburdened systems. This was brought up specifically in a 2024 research published in JMIR Cancer, which noted that patients who received alerts from smartphone-based cancer screening had a real risk of overinvestigating the results.
What happens to this health data when it is obtained is another legitimate concern. The information becomes more sensitive and appealing to insurers, employers, and data brokers the more thorough and ongoing the surveillance. The FDA’s strategy for AI-powered health software is still developing, and regulatory frameworks are still catching up with the technology. Continuous background monitoring that doesn’t require user input is one of the most beneficial applications, but it also raises the most serious privacy concerns.
Nevertheless, it’s difficult to ignore how far smartphone health sensing has come in the last few years. Preventive care would be significantly altered by a device that could accurately identify early-stage atrial fibrillation, detect respiratory deterioration before to hospitalization, or identify behavioral changes that precede a depressive episode using gear that someone already owns. It’s no longer truly an issue of whether it’s feasible. How accurately and fairly it can be done is the question.
